Cargando…
163 The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment in Patients With Hereditary Angioedema Due to C1-Inhibitor Deficiency
BACKGROUND: Management of hereditary angioedema (HAE) comprises the prophylaxis and emergency treatment of edematous attacks. Our aim was to appraise the wide variety of the prophylactic use of plasma-derived human C1-inhibitor concentrate in HAE type I and type II patients. METHODS: 125 patients wi...
Autores principales: | Csuka, Dorottya, Zotter, Zsuzsanna, Szabó, Erika, Kelemen, Zsuzsanna, Farkas, Henriette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512692/ http://dx.doi.org/10.1097/01.WOX.0000411920.42955.9f |
Ejemplares similares
-
86 The Efficacy and Safety of Human Plasma-derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012) -
458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012) -
455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012) -
Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence
por: Andrási, Noémi, et al.
Publicado: (2022) -
Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)